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Intrinsic immune responses autonomously inhibit
viral replication and spread. One pathway that re-
stricts viral infection in plants and insects is RNA
interference (RNAi), which targets and degrades viral
RNA to limit infection. To identify additional genes
involved in intrinsic antiviral immunity, we screened
Drosophila cells for modulators of viral infection
using an RNAi library. We identified Ars2 as a key
component of Drosophila antiviral immunity. Loss
of Ars2 in cells, or in flies, increases susceptibility
to RNA viruses. Consistent with its antiviral proper-
ties, we found that Ars2 physically interacts with
Dcr-2, modulates its activity in vitro, and is required
for siRNA-mediated silencing. Furthermore, we show
that Ars2 plays an essential role in miRNA-mediated
silencing, interacting with the Microprocessor and
stabilizing pri-miRNAs. The identification of Ars2 as
a player in these small RNA pathways provides new
insight into the biogenesis of small RNAs that may
be extended to other systems.
INTRODUCTION
Innate immunity is the most ancient line of defense against path-
ogens. In mammals, the innate immune system provides the
initial response to infection and primes the adaptive immune
response. In contrast, invertebrates and plants lack adaptive
immunity and therefore rely solely on innate mechanisms to
combat infections. Recent studies have identified RNA interfer-
ence (RNAi) as an ancient, cell-intrinsic immune mechanism
that controls RNA viruses in plants and insects (Ding andVoinnet,
2007). RNAi is one of several small RNA-dependent silencing
pathways that control gene expression in a sequence-specific
manner in plants and animals. Small RNA-driven silencing is initi-
ated by an RNase III enzyme Dicer, which produces RNA
duplexes of approximately 21 nucleotides through the cleavage340 Cell 138, 340–351, July 24, 2009 ª2009 Elsevier Inc.of longer precursor molecules (Bernstein et al., 2001; Tomari
and Zamore, 2005; Zamore et al., 2000). Once generated, the
duplex is incorporated into the multiprotein RNA-induced
silencing complex (RISC) where one strand of the duplex is pref-
erentially retained (Hammond et al., 2000; Khvorova et al., 2003;
Schwarz et al., 2003). This guide strand directs RISC to a homol-
ogous target, where an Argonaute protein (Ago) mediates post-
transcriptional gene silencing (Hutvagner and Simard, 2008).
In Drosophila, small-interfering RNAs (siRNAs), which are
derived from exogenous or endogenous sources of double-
stranded RNA (dsRNA), are generated by Dicer-2 (Dcr-2) and
incorporated into an Ago2-dependent RISC, leading to the
degradation of complementary mRNAs or viral RNAs (Kim
et al., 2006). In contrast, endogenous primarymiRNA (pri-miRNA)
transcripts are processed into pre-miRNAs in the nucleus by the
Microprocessor, which includes the RNase III enzyme Drosha
and its binding partner Pasha (Denli et al., 2004). Next, the pre-
miRNAs are exported and further processed by cytoplasmic
Dicer-1 (Dcr-1) into mature miRNAs (Lee et al., 2004). Mature
miRNAs are incorporated into an Ago1-dependent RISC and
mediate translational inhibition of target transcripts (Okamura
et al., 2004).
Studies using mutants in the known components of the clas-
sical siRNA pathway, including Dcr-2, r2d2, and AGO2, revealed
the essential antiviral role that RNAi plays against positive-
stranded RNA viruses in Drosophila (Galiana-Arnoux et al.,
2006; van Rij et al., 2006; Wang et al., 2006). We set out to iden-
tify additional cellular components of the Drosophila intrinsic
antiviral arsenal. An unbiased screen for factors that, when
lost, led to increased viral replication identified Ars2 (CG7843).
Ars2 is a poorly characterized gene that is highly conserved
and required for development in Arabidopsis, zebrafish, and
mice (Amsterdam et al., 2004; Prigge and Wagner, 2001; Wilson
et al., 2008). The best characterized Ars2 homolog isArabidopsis
SERRATE, which recently emerged as a component of the
miRNA biogenesis pathway (Lobbes et al., 2006; Yang et al.,
2006). In plants, Ars2 genetically interacts with the nuclear
cap-binding complex (CBC) components ABH1/CBP80 and
CBP20 (Laubinger et al., 2008). Both our study and the work in
the accompanying manuscript now reveal a physical interaction
between Ars2 and the CBC in Drosophila and mammals (Gruber
et al., 2009 [this issue ofCell]). We further demonstrate that Ars2,
along with the CBC, plays a role in antiviral immunity against
a battery of RNA viruses and is required for both siRNA- and
miRNA-mediated silencing, controlling the biogenesis of small
regulatory RNAs.
RESULTS
Ars2 Is a Restriction Factor for VSV Replication
To identify novel genes that control viral replication, we per-
formed a small-scale screen for cellular factors that allow
increased viral replication in cells when depleted by RNAi. We
used a Drosophila cell culture system for these studies due to
the high potency of RNAi, low genomic redundancy, and lack
of a complicating interferon response. To screen for such host
factors, we treated Drosophila cells with dsRNA, incubated the
cells for 3 days to allow for loss-of-function phenotypes, and
challenged the cells with the mammalian virus Vesicular Stoma-
titis Virus (VSV). VSV is an enveloped, negative-stranded RNA
virus that is naturally transmitted to mammals from insects
(Letchworth et al., 1999; Lyles and Rupprecht, 2007). To monitor
infection, we used a recombinant virus that expresses the
reporter GFP upon replication (Ramsburg et al., 2005). Treat-
ment with dsRNA against GFP is used as a positive control for
silencing, as it is expressed by the virus upon replication. Lucif-
erase dsRNA is used as a nontargeting control, as it is not ex-
pressed in this system. Using a fluorescence assay we found
that VSV readily infects Drosophila cells, and that RNAi-medi-
ated depletion of GFP can be monitored by microscopy
(Figure 1A). Using this strategy we screened approximately
100 genes and identified CG7843, the Drosophila homolog of
mammalian Ars2, which led to an increase in the percentage of
VSV-infected cells when depleted by RNAi (Figure 1A). To vali-
date that the increase in infection was due to a depletion of
Ars2 rather than an off-target effect, we generated an indepen-
dent dsRNA to Ars2 and observed a similar increase in VSV
infection (Figure 1A). Effective knockdown of Ars2 was verified
by northern blot analysis (Figure 1C).
We next measured several characteristics of control and Ars2-
deficient cells during VSV infection (Figure 1B). The percentage
of infected cells was quantified using automated image analysis;
an average 5-fold increase in the percentage of infected cells
was observed in Ars2 knockdown cells compared to control
cells. In addition, we found that depletion of Ars2 resulted in a
small but consistent 10%–15% decrease in cell number, sug-
gesting that Ars2 may play a role in cell proliferation or viability.
Since the expression of the GFP reporter can be measured
directly by fluorescence, the average intensity of the GFP signal
in each infected cell serves as surrogate for the amount of viral
replication per cell. Using automated image analysis we found
that the average GFP intensity in Ars2-deficient cells was
1.5-fold higher than that in control cells (Figure 1B). Because
Ars2-deficient cells display enhanced permissivity to VSV infec-
tion and support increased viral replication upon infection, our
data suggest that Ars2 may normally act in an antiviral manner
to limit viral replication in Drosophila cells.Ars2 Restricts the Replication of a Panel of RNA Viruses
To determine whether this cellular restriction factor is a specific
inhibitor of VSV or whether it plays a more general antiviral role,
we tested whether depletion of Ars2 influenced the infectivity of
a panel of disparate RNA viruses (Figure 2A). These viruses
included Drosophila C Virus (DCV), Flock House Virus (FHV),
and Sindbis virus (SIN), which were chosen because they
have all been previously shown to infect Drosophila and
because they represent diverse families of RNA viruses that
are arthropod-borne. DCV, a dicistrovirus, is related to mam-
malian picornaviruses and is a natural Drosophila pathogen
(Cherry and Perrimon, 2004; Johnson and Christian, 1998).
DCV and the nodavirus FHV, another insect pathogen, represent
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Figure 1. Ars2 Controls VSV Infection in Cell Culture
(A) Cells were treated with the indicated dsRNAs; Ars2 #1 and #2 denote inde-
pendent dsRNA amplicons. Infected cells expressing a VSV-encoded GFP
reporter are shown in green, nuclei in blue.
(B) Infected Ars2-deficient cells were normalized to infected control cells
and percent infection, cell number, and average intensity were quantified.
* denotes p < 1 3 105; error bars indicate ± standard deviation (SD) from
a representative experiment. Experiment was repeated five times.
(C) Northern analysis of cells treated with the indicated dsRNAs.Cell 138, 340–351, July 24, 2009 ª2009 Elsevier Inc. 341
nonenveloped, positive sense RNA viruses (Friesen, 2007;
Venter and Schneemann, 2008). SIN is an alphavirus and serves
as a model for enveloped, positive sense RNA viruses (Griffin,
2007). In addition, we chose to test Vaccinia virus, a large dsDNA
virus, which is the prototypical member of the poxvirus family of
viruses (Damon, 2007).
To investigate the role of Ars2 during infection with this
diverse panel of viruses, control and Ars2-deficient cells were
challenged with each virus, visualized by immunofluorescence
microscopy, and quantified using automated image analysis
(Figure 2B). Knockdown of Ars2 increased infection of DCV,
FHV, and SIN by at least 2-fold (Figure 2C). In contrast, Vaccinia
virus infection was unaffected by Ars2 depletion. Vaccinia virus
has a DNA genome, while the genomes of Ars2-sensitive viruses
are encoded by RNA. The differential effects of Ars2 depletion on
RNA and DNA viruses suggest that Ars2may act in an RNA virus-
specific manner.
Ars2 Restricts Viral RNA Production in Cultured Cells
Viral infection involves a sequential series of steps from entry to
RNA transcription, RNA replication, translation, and finally
assembly and release. To characterize the mechanism of Ars2
antiviral action, we investigated the step in the RNA virus life
cycle that is inhibited by Ars2. To independently verify that
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Figure 2. Ars2 Controls Infection of a Panel
of RNA Viruses in Cell Culture
(A) Table of the name and the physical properties
of each virus.
(B) Immunofluorescence of DL1 cells infected with
a diverse panel of viruses. Cells were treated with
dsRNAs against Ars2 or control. Virus antigen is
shown in green, nuclei in blue.
(C) Quantification of images in (B). All values were
significant at p < 0.0001; error bars indicate ± SD
of three independent experiments.
Ars2 knockdown allows enhanced pro-
duction of viral protein products, immu-
noblot analysis of VSV-infected cells
was performed (Figure 3A). We treated
cells with dsRNAagainst VSVMas a posi-
tive control. Using this assay, we found
that cells depleted of Ars2 expressed
higher levels of viral M protein than
control cells, consistent with the immuno-
fluorescence assay. Likewise, we tested
whether loss of Ars2 also led to an
increase in DCV antigen production by
immunoblot. Whereas treatment with
dsRNA against the viral genome inhibited
viral antigen production compared to
a nontargeting control, depletion of Ars2
led to a significant increase in the levels
of DCV capsid protein production (Fig-
ure 3B).
Increased viral protein production in
Ars2-deficient cells may be due to en-
hanced translation of viral mRNA or an increase in any step
prior to translation. To determine whether there is a difference
in viral RNA production in Ars2-deficient cells, we used northern
blotting tomeasure viral RNA levels. Wemonitored VSV infection
by measuring viral GFP mRNA and found that VSV mRNA
levels are increased in Ars2-depleted cells compared to negative
control cells (Figure 3C). Similarly, we found that DCV RNA
levels were increased in Ars2-deficient cells compared to control
cells (Figure 3D). Together, this suggests that the restriction of
viral replication is not due to reduced translation of viral
transcripts, but rather Ars2 is acting at the level of RNA replica-
tion or stability or at an earlier step in the viral life cycle, such as
entry.
To determine whether Ars2 depletion affects viral entry, we
performed an entry assay similar to that used by Otsuka et al.
(2007). Drosophila cells were treated with dsRNA against Ars2
or a control and infected with VSV, and levels of internalized viral
M protein were measured by immunoblot. Ars2-deficient cells
did not display an increase in internalized VSV antigen when
compared to control cells (Figure 3E). We next tested whether
loss of Ars2 affected DCV entry and did not observe a difference
in the amount of internalized DCV capsid protein when com-
paring Ars2-deficient cells to the negative control (Figure 3F).
These findings suggest that Ars2 restricts RNA virus infection342 Cell 138, 340–351, July 24, 2009 ª2009 Elsevier Inc.
at a common step in the viral life cycle that is downstream of
entry and is likely at the level of RNA replication or stability.
Ars2 Plays an Antiviral Role in Adult Flies
The above findings indicate a critical role for Ars2 in cultured
cells. To extend the requirements for Ars2 to the organismal level
during virus infection, we obtained two independent transposon
insertion fly lines in Ars2 (c00735, e01128) that are lethal alleles
and are unable to complement one another (Figure 4A). There-
fore, Ars2 is an essential gene in Drosophila, prohibiting studies
during adult stages. To generate hypomorphic alleles, we used
the Gal4/UAS system to drive expression of a UAS-Ars2 inverted
repeat transgene (UAS-Ars2 IR), which bears a long hairpin
dsRNA construct targeting endogenous Ars2. Expression of
UAS-Ars2 IR is controlled by the UAS-binding protein Gal4.
UAS-Ars2 IR serves as a substrate for RNAi, leading to loss-of-
function phenotypes in vivo. To characterize the developmental
requirements of Ars2, we expressed UAS-Ars2 IR ubiquitously,
at high levels using an Actin promoter or at low levels using
a daughterless (da) promoter driving Gal4. In both cases, ubiqui-
tous expression of the dsRNA was lethal (Figure 4A). To bypass
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B Figure 3. Ars2 Controls Viral RNA Levelsduring RNA Virus Infection
(A) Immunoblot analysis of cells pretreated with
the indicated dsRNAs either uninfected or infected
with VSV as indicated.
(B) Immunoblot analysis of cells pretreated with
the indicated dsRNAs either uninfected or infected
with DCV as indicated.
(C) Northern blot analysis of cells pretreated with
the indicated dsRNAs either uninfected or infected
with VSV as indicated.
(D) Northern blot analysis of cells pretreated with
the indicated dsRNAs either uninfected or infected
with DCV as indicated.
(E) Entry assay by immunoblot analysis. Cells pre-
treated with the indicated dsRNAs were either
uninfected or infected with VSV, extracellular virus
was removed, and immunoblot analysis was per-
formed against internalized VSV (VSVM) or control
(tubulin).
(F) Entry assay by immunoblot analysis. Cells pre-
treated with the indicated dsRNAs were either
uninfected or infected with DCV, extracellular virus
was removed, and immunoblot analysis was per-
formed against internalized DCV (capsids) or the
control (tubulin).
the developmental requirement of Ars2,
we drove the expression of UAS-Ars2 IR
using a heat shock (hs) promoter that
can be induced at 37C. Raising the flies
at 25C allowed the generation of wild-
type numbers of flies that were induced
to express Ars2 dsRNA as adults
(Figure 4A).
We expressed the Ars2 hairpin in trans-
genic flies by pulsing hs-Gal4 >UAS-Ars2
IR or controls at 37C. We challenged the
Ars2-depleted or control flies with either carrier (PBS) or DCV
and monitored mortality as a function of time post-injection.
Depletion of Ars2 does not affect viability post-PBS challenge
(Figure 4B). In contrast, there was a significant shift in the survival
curve upon loss of Ars2 when challenged with the natural path-
ogen DCV. The Ars2-depleted flies succumb to the infection
earlier than the control flies (Figure 4B). To determine if lethality
is due to increased viral replication, we challenged control or
Ars2-depleted flies with DCV and monitored viral protein pro-
duction. Under these conditions we observed increased pro-
duction of viral capsid proteins upon depletion of Ars2
(Figure 4C).
Next, we determined whether flies challenged with VSV were
also sensitive to loss of Ars2. Again, we infected either the
Ars2-depleted flies or control flies with VSV and found that while
control flies or wild-type flies do not succumb to infection by
VSV, there was a significant increase in mortality upon loss of
Ars2 (Figure 4D, data not shown). Again, we observed increased
viral protein production upon depletion of Ars2 (Figure 4E). This
demonstrates that Ars2 plays an antiviral role against disparate
RNA viruses both in cultured cells and in vivo in adult flies.Cell 138, 340–351, July 24, 2009 ª2009 Elsevier Inc. 343
Ars2 Is Required for siRNA- and esiRNA-Mediated
Silencing
Since Ars2 is antiviral against a panel of RNA viruses that have
been shown to be susceptible to antiviral RNAi (Galiana-Arnoux
et al., 2006; van Rij et al., 2006; Wang et al., 2006), we tested
whether lossofArs2 impacts siRNA-mediated silencing. For these
studies, we used a dual-reporter system that allowed us to simul-
taneously monitor transfection efficiency along with siRNA-
mediated silencing. Three inducible constructs were transfected
intoDrosophila cells: a Firefly Luciferase control reporter, a Renilla
Luciferase reporter, and a vector that produces a long Renilla-
specific dsRNA. Transfected cellswere depleted of RNA silencing
components, and Renilla levels were normalized to Firefly
control levels. Depletion of Dcr-2 or Ago2 led to a significant dere-
pression of Renilla, whereas treatmentwith a nontargeting control
orAgo1hadnoeffect onRenilla silencing (Figure5A). In this assay,
loss of Ars2 resulted in a 2-fold induction of Renilla, suggesting
that Ars2 plays a role in siRNA-mediated gene silencing.
Due to the finding that Ars2 is involved in siRNA silencing, we
hypothesized that Ars2may also play a role in silencingmediated
A
B C
ED
Figure 4. Ars2 Is Required for Antiviral
Immunity in Adult Flies
(A) Ars2 is developmentally required in Drosophila.
Table of Ars2 mutants and their phenotypes is
shown.
(B) Adult flies carrying heat-shock-inducible Gal4
were crossed to flies that can be induced to
express dsRNA against Ars2 (hs-Gal4>UAS-Ars2
IR) or controls (hs-Gal4>+). Adult progeny controls
(open circles) or Ars2-deficient flies (open trian-
gles) were challenged with vehicle (PBS) and
mortality was monitored as a function of time
post-injection. In addition, control (closed circles)
or Ars2-deficient flies (closed triangles) were chal-
lenged with DCV and mortality was monitored
as a function of time post-infection. Percent
survival is graphed as a function of time (p < 0.001,
log-rank test comparing infected controls to in-
fected Ars2-deficient flies). A representative of at
least three experiments is shown.
(C) Immunoblot analysis of flies that are either
depleted for Ars2 (mut) or controls (WT) as de-
scribed in (B), infected with DCV, and collected
at the indicated time points post-infection.
(D) Ars2-deficient flies (triangles) or controls
(circles) as described in (B) were challenged with
VSV and monitored daily for mortality; percent
survival is graphed as a function of time (p <
0.001, log-rank test). A representative of at least
three experiments is shown.
(E) Immunoblot analysis of flies that are either
depleted for Ars2 (mut) or controls (WT) as
described in (B), infected with VSV, and collected
at the indicated time points post infection.
by endogenous siRNAs (esiRNAs) that
are normally produced via a Dcr-2/
Ago2-dependent pathway (Czech et al.,
2008; Ghildiyal et al., 2008; Kawamura
et al., 2008; Okamura et al., 2008). To
test this possibility, a Renilla reporter fused to mus308 was em-
ployed. The mus308 transcript is a natural cellular target of esi-
2.1 (Okamura et al., 2008), thus the reporter is silenced by the
endogenous pools of esi-2.1. Knockdown of negative controls
b-gal and Ago1 had no effect on reporter silencing, whereas
Dcr-2 and Ago2 depletion alleviated the repression of the Re-
nilla-mus308 reporter (Figure 5B). Loss of Ars2 led to a more
than 2-fold induction of Renilla; similar results were also
observed using a Renilla reporter bearing two esi-2.1 target sites
(Figure S1 available online). Taken together, these data suggest
that Ars2 is required for esiRNA-mediated silencing.
Ars2 Is Required Upstream of RISC
To determine the step in the siRNA pathway for which Ars2 func-
tion is required, we tested whether introduction of siRNAs rather
than long dsRNAs could bypass the requirement for Ars2. Cells
were cotransfected with Firefly and Renilla reporters and bathed
indsRNAs todepleteRNAsilencingcomponents.Cellswere then
transfected with nontargeting or Renilla-specific siRNAs. We
found that the Renilla-specific siRNAs reduced Renilla344 Cell 138, 340–351, July 24, 2009 ª2009 Elsevier Inc.
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Figure 5. Ars2 Is Required for siRNA-Mediated Silencing
(A) Cells were transfected with a control reporter (Firefly), a Renilla reporter, and a vector expressing a Renilla hairpin. The indicated proteins were depleted by
RNAi and cells were monitored for siRNA-mediated silencing. * denotes p < 1 3 105.
(B) Cells were transfected with a control vector (Firefly) and Renilla-mus308. The indicated proteins were depleted by RNAi and the cells were monitored for
esiRNA-mediated silencing. * denotes p < 1 3 105.
(C) Cells were transfected as in (A); however, siRNA duplexes against Renilla were transfected in lieu of the long hairpin trigger vector. * denotes p < 0.001.
(D) Northern blot analysis of esi-2.1 in cells depleted as indicated. esi-2.1 expression was quantified relative to the 2S rRNA, and values were normalized to the
Luciferase negative control.
(E) Cells expressing NTAP-Ars2 and either FLAG-Ran or FLAG-Dcr-2 were immunoprecipitated, treated with RNase as indicated, and immuoblotted for FLAG.
Left panel shows 1/10 input and the right panel shows the coimmunoprecipitate.
(F) Cytoplasmic extracts from cells expressing FLAG-Dcr-2 were depleted for Ars2 or Luciferase control (Con) and incubated with a uniformly radiolabeled dsRNA
substrate to measure siRNA-generating activity.
(G) Quantification of siRNA production normalized to the siRNA-generating activity of the control extract. * denotes p < 0.05.
Error bars represent ± SD of three independent experiments.expression by 40% in control cells treated with b-gal dsRNA
(Figure 5C). Renilla expression in Ago2-deficient cells was unaf-
fected by the introduction of Renilla siRNAs since Ago2 is thecatalytic core of RISC and mediates the downstream effector
steps of the pathway (Okamura et al., 2004). When Dcr-2- or
Ars2-deficient cells were transfected with Renilla-specificCell 138, 340–351, July 24, 2009 ª2009 Elsevier Inc. 345
siRNAs, the reporter was silenced as efficiently as in b-gal control
cells. Thesedata suggest thatArs2 is important for siRNAbiogen-
esis but is dispensable for the effector functions of the pathway.
Ars2 Controls the Production of Endogenous siRNAs
Since our Luciferase reporter assays suggested a role for Ars2 in
an upstreambiogenesis step of RNA silencing, and given that the
repression of the esiRNA reporter was controlled by esi-2.1
(Figure 5B), we used northern blotting to examine the steady-
state levels of esi-2.1 upon depletion of either controls or Ars2
(Figure 5D). As expected, loss of Dcr-2 or Ago2 but not Dcr-1
led to a decrease in the accumulation of esi-2.1 compared to
a nontargeting control (Luciferase). Furthermore, we found that
depletion of Ars2 reduced the levels of esi-2.1, demonstrating
that Ars2 controls the bona fide endogenous siRNA pools.
Ars2 Physically Interacts with Dcr-2
Given that Ars2 is required upstream of RISC, we tested whether
Ars2 can physically interact with the most upstream siRNA
pathway component known, Dcr-2. To this end, we expressed
NTAP-Ars2 in Drosophila cells along with either a control protein
(FLAG-Ran) or FLAG-Dcr-2. Immunoprecipitation of NTAP-Ars2
followed by immunoblot analysis showed that Ars2 coprecipi-
tates Dcr-2 but not the control protein (Figure 5E). Moreover,
the interaction with Dcr-2 is RNA independent. Therefore, our
data suggest that Ars2 mediates its effects on the siRNA
pathway through an interaction with cytoplasmic Dcr-2.
Cytoplasmic dsRNA Processing Requires Ars2
Our findings implicate Ars2 in the early steps of siRNA silencing,
both functionally and biochemically. To test the relevance of this
interaction on Dcr-2 activity directly, we determined whether the
dsRNA processing activity of Dcr-2 was dependent upon Ars2
in vitro. Drosophila cells expressing FLAG-Dcr-2 were depleted
of endogenous Ars2 or a negative control (Luciferase) by RNAi,
and cytoplasmic extracts were incubated with a uniformly radio-
labeled dsRNA. siRNA production was significantly reduced in
Ars2-depleted lysates (Figure 5F). Replicate experiments indi-
cate that loss of Ars2 results in an approximately 2-fold attenua-
tion of dsRNA processing (Figure 5G). These data suggest that
Ars2 is required for the efficient processing of siRNA pathway
substrates by Dcr-2 and provide a mechanism for the Ars2
requirement in cytoplasmic siRNA silencing.
Ars2 Is Required for miRNA-Mediated Silencing
Studies in plants have found that SERRATE, the plant homolog of
Ars2, plays a role inmiRNA biogenesis (Lobbes et al., 2006; Yang
et al., 2006). Moreover, inDrosophila, loss of Ars2 is lethal, as are
mutants in the miRNA pathway but not mutants in the siRNA
pathway (Figure 4A) (Lee et al., 2004; Okamura et al., 2004).
Therefore, using another Luciferase-based reporter assay, we
tested whether Ars2 is also involved in miRNA silencing. Cells
were transfected with a Firefly Luciferase control, a construct
expressing pri-miR-277, and a Renilla reporter bearing four
bulged miR-277 target sites. miR-277 is a Drosophila miRNA
that was shown to silence bulged targets through the canonical
miRNA silencing pathway (Forstemann et al., 2007). Knockdown
of negative controls b-gal, Dcr-2, and Ago2 had little effect on346 Cell 138, 340–351, July 24, 2009 ª2009 Elsevier Inc.reporter silencing, while depletion of Ago1, a core component
of miRNA RISC, resulted in a significant loss of repression of
the Renilla reporter (Figure 6A). Under these conditions, loss of
Ars2 resulted in a significant increase in Renilla expression,
revealing that Ars2 is required for miRNA-mediated silencing in
addition to siRNA-mediated silencing.
Ars2 Is Required Upstream of pre-miRNA Production
To further characterize the role of Ars2 in themiRNApathway, we
monitored the steady-state levels of endogenous bantam
miRNA. First, we examined by northern blotting the levels of
mature bantam upon depletion of controls or Ars2. As expected,
loss of Ago1 had a significant effect on the levels of the mature
miRNA (Figure 6B). In contrast, while Dcr-1 is required to pro-
duce mature miRNAs, it has been previously shown that tran-
sient Dcr-1 knockdown has little effect on the steady-state levels
of mature bantam and instead has a much stronger effect on the
levels of pre-bantam (Figure 6B) (Forstemann et al., 2005).
Depletion of Ars2 had little effect on the accumulation of mature
bantam but resulted in an approximately 2-fold reduction in
pre-bantam. We reasoned that if Ars2 was required upstream
of Dcr-1, then loss of Ars2 would suppress the accumulation of
pre-bantam observed upon loss of Dcr-1. As a positive control
we depleted cells of both Dcr-1 andDrosha, the core component
of the upstream Microprocessor, and indeed found that loss of
Drosha suppressed the accumulation of pre-bantam. When
Ars2 was depleted in combination with Dcr-1, there was a reduc-
tion in the accumulated levels of pre-bantam (Figure 6B). This
observation places Ars2 upstream of Dcr-1 activity, likely at
the level of the Microprocessor.
Primary miRNA Transcripts Are Depleted
in the Absence of Ars2
Given that the steady-state levels of pre-bantam are reduced
upon loss of Ars2, we next used RT-PCR to examine the levels
of primary bantam (pri-bantam) miRNA transcripts. Loss of
Drosha resulted in a strong accumulation of pri-bantam, as the
enzyme is required for the liberation of pre-bantam from the
primary transcript (Figure 6C, top panel) (Lee et al., 2003). In
contrast, depletion of Ars2 did not result in an accumulation of
pri-bantam; rather, the levels were slightly less than the b-gal-
negative control cells. A decrease in pri-miRNA levels upon
Ars2 knockdown was also observed in mammalian cells (Gruber
et al., 2009). One possible explanation is that Ars2 is important
for the stability of primarymiRNA transcripts. To test this hypoth-
esis, we codepleted both Drosha and Ars2 from cells, reasoning
that if Ars2 stabilizes pri-miRNAs, then pri-bantam will not accu-
mulate in cells lacking both Drosha and Ars2, since unprocessed
transcripts will be degraded. Indeed, we found that, compared to
b-gal/Drosha-depleted cells, Ars2/Drosha-depleted cells had
decreased levels of pri-bantam (Figure 6C, bottom panel). These
data suggest that Ars2 is required upstream or at the level of the
Microprocessor during miRNA biogenesis and support the idea
that Ars2 is necessary to stabilize primary transcripts.
Ars2 Physically Interacts with the Microprocessor
We next tested whether Ars2 could physically interact with the
Microprocessor (Drosha/Pasha). To this end, we expressed
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Figure 6. Ars2 Is Required for miRNA-Mediated Silencing
(A) Cells were transfected with a control reporter (Firefly), a vector
expressing pri-miR-277, and a Renilla reporter bearing bulged
miR-277 target sites. The indicated proteins were depleted by
RNAi and the cells were monitored for miRNA-mediated silencing.
* denotes p < 0.0001; error bars represent ± SD of three indepen-
dent experiments.
(B) Northern blot analysis of pre- and mature bantam miRNA.
Expression of pre- and mature bantam was quantified relative to
the 2S rRNA, and values were normalized to b-gal.
(C) RT-PCR analysis of pri-bantam and cellular control transcript
(clathrin heavy chain) levels in cells depleted as indicated. Serial
5-fold dilutions indicate amplification in the linear range.
(D) Cells expressing NTAP-Ars2 and either FLAG-Ran or FLAG-
Pashawere immunoprecipitated, treatedwith RNase as indicated,
and immuoblotted for FLAG. Left panel shows the 1/10 input and
the right panel shows the coimmunoprecipitate.Cell 138, 340–351, July 24, 2009 ª2009 Elsevier Inc. 347
NTAP-Ars2 in Drosophila cells along with either a control protein
(FLAG-Ran) or FLAG-Pasha. Immunoprecipitation of NTAP-Ars2
followed by immunoblot analysis showed that Ars2 coprecipi-
tates Pasha but not the control protein in an RNA-independent
manner (Figure 6D). Therefore, our data suggest that Ars2 medi-
ates its effects on the miRNA pathway through an interaction
with the Microprocessor.
The CBC Controls Small RNA Silencing Pathways
In mammalian systems, Ars2 physically interacts with and shut-
tles between the nucleus and cytoplasm with the nuclear CBC
proteins CBP20 and CBP80 (Gruber et al., 2009). Therefore,
we tested whether the corresponding biochemical complex
exists inDrosophila. We generated a polyclonal antibody against
Ars2 and used it to detect overexpressed Ars2 since endoge-
nous Ars2 levels were undetectable in input lysates (Figure 7A).
We found that NTAP-Cbp20 specifically immunoprecipitates
Ars2 and not a control protein (FLAG-Ran), suggesting that the
Ars2 interaction with the CBC is conserved in Drosophila
(Figure 7A).
B C
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Figure 7. The CBC Interacts with Ars2 and
Restricts RNA Virus Infection
(A) Cells expressing NTAP-Cbp20 and either
control (FLAG-Ran) or Ars2 (pMT-Gal4 > UAS-
Ars2) were immunoprecipitated and immunoblot-
ted for FLAG and Ars2. Left panel shows the
1/10 input and the right panel shows the coimmu-
noprecipitate. * denotes nonspecific cross-react-
ing proteins.
(B) Fluorescence of cells pretreated with dsRNAs
against the indicated genes and infected with
VSV. Infected cells expressing GFP are shown in
green, nuclei in blue.
(C) Percent infection was calculated by dividing
the number of GFP-positive cells by the total
number of cells. * denotes p < 1 3 108.
(D) Immunofluorescence of cells pretreated with
dsRNAs against the indicated genes and infected
with DCV. Infected cells expressing capsids are
shown in green, nuclei in blue.
(E) Percent infection was calculated by dividing the
number of DCV-positive cells by the total number
of cells. * denotes p < 1 3 108.
Error bars represent ± SD of three independent
experiments.
Since Ars2 is important for small RNA
silencing, we hypothesized that Ars2-
binding partners may also be required
for siRNA-, esiRNA-, and miRNA-medi-
ated silencing. Indeed, cells depleted of
Cbp20 or Cbp80 are defective in all three
modes of silencing (Figures 5A, 5B, and
6A). Furthermore, we found that the
CBC phenocopies Ars2 in each of the
assays used to place Ars2 in the RNA
silencing pathways. Like Ars2, the CBC
components function in the early steps
of the siRNA pathway; mature Renilla-
specific siRNAs are able to effectively silence the Renilla reporter
in CBC-depleted cells (Figure 5C), and steady-state levels of esi-
2.1 are reduced in the absence of Cbp20 (Figure 5D). Moreover,
the CBC acts at the level of the Microprocessor in the miRNA
pathway; depletion of Cbp20 leads to a decrease in pre- and
pri-bantam accumulation (Figures 6B and 6C), implicating the
CBC in pri-miRNA stability.
The CBC Controls Viral Replication
Given that the CBC binds Ars2 and is necessary for siRNA
silencing,we testedwhether theCBCalsoplaysa role in restricting
viral infection. To this end, cells were depleted by RNAi for Lucif-
erase as a negative control, Ago2 as a positive control for the
antiviral RNAi pathway, or our candidates Cbp20 and Cbp80.
The cells were then challenged with VSV or DCV and imaged by
fluorescence microscopy (Figures 7B and 7D). Automated image
analysis quantified the percentage of infected cells (Figure 7C and
7E). Depletion of Ago2, Cbp20, or Cbp80 resulted in enhanced
infection of two disparate RNA viruses VSV (Figure 7C) and DCV,
which replicates using an uncapped viral RNA (Figure 7E).348 Cell 138, 340–351, July 24, 2009 ª2009 Elsevier Inc.
DISCUSSION
Our findings demonstrate that Ars2 and the CBC are required for
miRNA- and siRNA-mediated silencing as well as antiviral
defense in Drosophila. In the accompanying manuscript, Gruber
et al. report a similar role for Ars2 in mammalian miRNA-medi-
ated silencing (Gruber et al., 2009). Ars2 and the CBC are
required at upstream steps in both Drosophila and mammalian
RNA silencing pathways, which is consistent with recent data
from plants; the Ars2 homolog SERRATE and homologs of the
CBC (ABH1 and CBP20) control pri-miRNA processing in Arabi-
dopsis (Gregory et al., 2008; Laubinger et al., 2008; Lobbes et al.,
2006; Yang et al., 2006). Ars2 functionally and biochemically
interacts with the nuclear Microprocessor, as does SERRATE,
which physically interacts with HYL1, a component of the
Arabidopsis miRNA biogenesis pathway similar in function to
Drosophila Pasha and mammalian DGCR8 (Lobbes et al.,
2006; Yang et al., 2006).
The results of our studies, combined with the evidence from
existing literature, have led us to propose two potential models
for Ars2 function. The first is a bridging model in which Ars2
serves as a recruitment factor to guide the RNA processing
machinery to the proper substrates. Under this model, Ars2
and the CBC bind pri-miRNA transcripts through recognition of
their 50 cap, and Ars2 actively recruits the Microprocessor to
the transcript, promoting its cleavage into a pre-miRNA. This
bridging model suggests a mechanism by which Ars2 and the
CBC increase the efficiency of pri-miRNA processing by acting
as chaperones to stabilize and deliver the primary transcripts
directly to theMicroprocessor. It then follows that in the absence
of Ars2 or the CBC, Drosha-directed pri-miRNA processing is
impaired since the recruitment of the Microprocessor to primary
transcripts is less efficient, and the unprocessed transcripts are
destabilized. Our finding that pri-bantam levels are reduced in
Ars2 or CBC-depleted cells (Figure 6C) along with similar find-
ings in mammalian cells (Gruber et al., 2009) support this model.
While the bridging model provides a compelling mechanism for
the Ars2 and CBC requirement in the miRNA pathway, it is less
likely to be relevant for the siRNA pathway, as the substrates
of the pathway (dsRNA, viral RNAs) are not necessarily 50 cap-
ped. Although it is possible that Ars2 recruits Dcr-2 to uncapped
substrates through the targeting of secondary RNA structure,
our data favor an RNA recognition-independent model.
This secondmodel proposes that Ars2 serves as a cofactor for
the enzymatic activity of RNase III enzymes. Under this model,
the presence of Ars2 in Drosha- or Dcr-2-containing complexes
promotes robust enzymatic cleavage of RNA substrates and
increases the fidelity of processing. Consistent with this model,
recent work by Dong et al. has shown that the addition of re-
combinant SERRATE to an in vitro pri-miRNA processing assay
enhances both the activity and the accuracy of DCL1 substrate
cleavage (Dong et al., 2008). Moreover, Gruber et al. demon-
strate in the accompanying manuscript that mammalian pri-
miRNA processing is altered in the absence of Ars2 (Gruber
et al., 2009). Our functional dicing assay demonstrates that
Dcr-2-mediated processing of long dsRNA is impaired in the
absence of Ars2 (Figures 5F and 5G), lending support to the
idea that Ars2 is an essential accessory factor for Dcr-2 activityon uncapped RNAs. Since the substrates of the cytoplasmic
siRNA pathway are not necessarily capped, this further argues
that the CBC may be required for the cofactor activity of Ars2
rather than for substrate recognition.
The underlying difference between the two models is the
precise step of substrate recognition and processing for which
Ars2 is required; the bridging model poses that Ars2 and the
CBC physically bind the RNA substrate, recruiting the proper
processing activity for cleavage. Conversely, the cofactor model
suggests that the binding of Ars2 and the CBC to the processing
machinery allows the enzymes to execute robust and accurate
substrate cleavage. Of course, these models are not mutually
exclusive, and the true function of Ars2 may combine aspects
of both models. Ars2 may also play distinct roles depending on
its particular binding partners or intracellular localization. Ulti-
mately, this study implicates Ars2 as a fundamental component
of several modes of RNA silencing and contributes to the
growing body of evidence that RNA silencing pathways are
more interconnected than previously appreciated (Zhou et al.,
2008). The RNA content of a cell is influenced by the contribu-
tions of many transcriptional and posttranscriptional regulatory
pathways that have evolved to respond quickly and sensitively
to the needs of the cell. The identification of novel components
of these pathways, such as Ars2, aids in our efforts to uncover
the mechanisms by which cellular processes such as prolifera-
tion or antiviral defense are exquisitely regulated.
EXPERIMENTAL PROCEDURES
Cells, Viruses, Antibodies, and Reagents
Drosophila cells were grown and maintained as previously described (Cherry
and Perrimon, 2004). VSV-eGFP (gift from J. Rose) was grown in BHK cells
as described (Ramsburg et al., 2005). FHV (gift from P. Ahlquist) was grown
in DL1 cells. Sindbis/GFP (gift from R. Hardy) was grown in C636 cells (Burn-
ham et al., 2007). DCV was grown and purified as described (Cherry and Per-
rimon, 2004). Vaccinia strain vPRA13 (gift fromR. Doms) was grown in HeLa S3
suspension cells (Alexander et al., 1992). Antibodies were obtained from the
following sources: anti-GFP (Invitrogen), anti-tubulin (Sigma), anti-VSVM (gift
from D. Lyles), anti-FHVB2 (gift from P. Ahlquist), anti-DCV (Cherry and Perri-
mon, 2004), anti-b-gal (Cappel). Rabbit polyclonal anti-Ars2 was generated
against purified GST-mouse Ars2 (Prosci). Fluorescently labeled secondary
antibodies were obtained from Jackson Immunochemicals, and HRP-conju-
gated antibodies from Amersham. Additional chemicals were obtained from
Sigma.
RNAi
dsRNAs were generated as described (Boutros et al., 2004). For RNAi, cells
were passaged into serum-free media and plated into wells containing dsRNA.
One hour later, complete media were added and cells were incubated for
3 days.
Viral Infections
Three days post-dsRNA addition, DL1 cells were infected with the indicated
viral inoculum. VSV (multiplicity of infection [moi] = 5), FHV (moi = 5), and
DCV (moi = 1.5) were added to cells and fixed at 24 hr post-infection. SIN
(moi = 15) was spinoculated at 1200 rpm for 2 hr and fixed at 36 hr post-infec-
tion. Vaccinia (moi = 1.5) was added to cells in 2% serum and the cells were
fixed at 48 hr post-infection.
Immunofluorescence
Cells were fixed in 4% formaldehyde/PBS, washed in PBS/0.1% Triton X-100
(PBST) twice, and blocked in 2% BSA/PBST. Primary antibody was diluted inCell 138, 340–351, July 24, 2009 ª2009 Elsevier Inc. 349
block and incubated overnight at 4C. Cells were washed and incubated in
secondary antibody for 1 hr at 25C. Cells were counterstained with
Hoescht33342 (Sigma) and imaged using automated microscopy (ImageX-
press Micro). Images of three sites per well were collected, with a minimum
of three wells per treatment, and percent infection was measured using
MetaXpress software.
Immunoblotting and Immunoprecipitations
For immunoblotting, cells or flies were collected and were lysed in radioimmu-
noprecipitation (RIPA) buffer supplemented with a protease inhibitor cocktail
(Boehringer). Samples were separated and blotted as previously described
(Cherry and Perrimon, 2004). For immunoprecipitations, S2 cells were pro-
cessed as previously described (Saito et al., 2005).
RNA Analysis
Total RNA was extracted from DL1 cells using Trizol (Invitrogen). To visualize
RNA species greater than 300 bp in length, total RNA was separated on
a 1% agarose/formaldehyde gel and blotted as previously described (Cherry
et al., 2005). For small RNA blots, total RNA was separated on a denaturing
polyacrylamide/urea gel and transferred to Hybond N+ (Amersham). Samples
were normalized against controls using ImageQuant. For RT-PCR, cDNA was
prepared from total RNA using M-MLV reverse transcriptase (Invitrogen)
random primers, and the indicated transcripts were amplified by PCR.
Entry Assay
DL1 cells were infected with either VSV (moi = 25) or DCV (moi = 15) for 2 hr in
the presence of cycloheximide (10 mg/ml). Cells were washed, treated with
0.25% trypsin/0.025% EDTA, then pelleted and washed again. Cells were
lysed in RIPA buffer supplemented with a protease inhibitor cocktail (Boeh-
ringer) and samples were immunoblotted as described above.
Adult Infections
Ars2 (c00735) and Ars2 (e01128) were obtained from the Exelixis collection at
Harvard Medical School. Flies carrying UAS-Ars2 IR (transformant 22574)
were obtained from the Vienna Drosophila RNAi Center. All other flies were
obtained from the Bloomington stock center. Flies carrying UAS-Ars2 IR or
control (wild-type or UAS-lacZ IR) were crossed to actin-Gal4, da-Gal4, or
hs-Gal4 at room temperature. On the day of injection the progeny from the
hs-Gal4 crosses were heat shocked at 37C for 1 hr and shocked every 2
days throughout the experiment. Four- to seven-day-old adults of the stated
genotypeswere inoculatedwith virus as previously described (Cherry and Per-
rimon, 2004). Flies were monitored daily for mortality or were processed at the
indicated time point post-infection. For survival curves, statistical significance
was determined with a log-rank test.
Luciferase Reporter Assays
To measure siRNA-, esiRNA-, or miRNA-mediated silencing, S2 cells were
transiently transfected with 1.2 mg pMT-Renilla, 40 ng pMT-Firefly, and 0.8 mg
pMT-Renilla-hairpin or with 2 mg pMT-Renilla-mus308 and 40 ng pMT-Firefly,
or with 100 ng pMT-Renilla 4B, 40 ng pMT-Firefly, and 2 mg pMT-miR277. Two
days post- transfection, cells were bathed in the indicated dsRNAs for 3 days.
For siRNA transfection experiments, 3 days post-bathing, Effectene was used
to transfect cells with Renilla-specific or nontargeting control siRNAs (Ambion)
at a final concentration of 20 nM. Reporters were induced with 200 mMCuSO4
and luminescence assays were performed 24 hr later using DualGlo following
the manufacturer’s protocol (Promega).
Dicing Assay
S2 cells were transfected with FLAG-Dcr-2 and bathed in dsRNA to deplete
the indicated protein. Cytoplasmic extracts were prepared as described (Saito
et al., 2005), and the dicing substrate was a 240 bp dsRNA that was uniformly
labeled with [a-32P]UTP during in vitro synthesis. Cleavage reactions were
carried out essentially as described (Liu et al., 2003) for 60 min at 29C after
which the RNA was extracted, and products were separated on a denaturing
polyacrylamide/urea gel, transferred to Hybond N+ (Amersham), and exposed
to a phosphoimager cassette.350 Cell 138, 340–351, July 24, 2009 ª2009 Elsevier Inc.SUPPLEMENTAL DATA
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